Racial differences in tobacco cessation and treatment usage after lung screening: An examination of the national lung screening trial

Oncologist

Volumn 21, Issue 1, 2015, Pages 40-49

  Kumar, Pallavi ^a   Gareen, Ilana F ^b   Lathan, Christopher ^c   Sicks, Jorean D ^b   Perez, Giselle K ^d   Hyland, Kelly A ^d,e   Park, Elyse R ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BROWN UNIVERSITY   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cancer screening; Lung cancer; Smoking cessation; Tobacco cessation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CEREBROVASCULAR ACCIDENT; CHRONIC BRONCHITIS; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HIGH RISK BEHAVIOR; HUMAN; LUNG CANCER; MALE; MEDICAL HISTORY; MIDDLE AGED; NICOTINE REPLACEMENT THERAPY; PASSIVE SMOKING; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING CESSATION; SMOKING CESSATION PROGRAM; SMOKING HABIT; TOBACCO DEPENDENCE; TOBACCO USE; ADVERSE EFFECTS; AFRICAN AMERICAN; CAUCASIAN; CONTROLLED STUDY; EARLY CANCER DIAGNOSIS; LUNG NEOPLASMS; PATHOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SMOKING;

AFRICAN AMERICANS; AGED; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SMOKING; SMOKING CESSATION; SURVEYS AND QUESTIONNAIRES;

EID: 84955310947     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2015-0325     Document Type: Article

References (54)

1. American Cancer Society. Cancer Facts & Figures. Atlanta, GA: American Cancer Society, 2012.
2. U. S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/2004/complete_report/index.htm. Accessed November 16, 2015.
3. National Lung Screening Trial Research Team, Aberle DR, Adams AM et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl JMed 2011; 365: 395–409.
4. Field JK, Smith RA, Aberle DR et al. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol 2012; 7: 10–19.
5. Taylor KL, Cox LS, Zincke N et al. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer 2007; 56: 125–134.
6. Moyer VA. Screening for lung cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 160: 330–338.
7. de Koning HJ, Plevritis SK, Hazelton WD et al. Benefits and Harms of Computed Tomography Lung Cancer Screening Programs for High-Risk Populations. AHRQ Publication No. 13-05196-EF-2. Rockville, MD: Agency for Healthcare Research and Quality, 2013.
8. de Koning HJ, Meza R, Plevritis SK et al. Benefits and harms of computed tomography lung cancer screening strategies: A comparativemodeling study for the U. S. Preventive Services Task Force. Ann Intern Med 2014; 160: 311–320.
9. Park ER, Japuntich SJ, Traeger L et al. Disparities betweenblacks andwhites in tobacco and lung cancer treatment. The Oncologist 2011; 16: 1428–1434.
10. Underwood JM, Townsend JS, Tai E et al. Racial and regional disparities in lung cancer incidence. Cancer 2012; 118: 1910–1918.
11. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008; 359: 1367–1380.
12. De Lancey JO, Thun MJ, Jemal A et al. Recent trends in black-white disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev 2008; 17: 2908–2912.
13. Lally BE, Geiger AM, Urbanic JJ et al. Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer 2009; 64: 226–231.
14. Yang R, Cheung MC, Byrne MM et al. Do racial or socioeconomic disparities exist in lung cancer treatment? Cancer 2010; 116: 2437–2447.
15. Esnaola NF, Gebregziabher M, Knott K et al. Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg 2008; 86: 220–227.
16. Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-smallcell lung cancer. J Clin Oncol 2006; 24: 413–418.
17. Lathan CS, Neville BA, Earle CC. Racial composition of hospitals: Effects on surgery for early-stage non-small-cell lung cancer. J Clin Oncol 2008; 26: 4347–4352.
18. Farjah F, Wood DE, Yanez ND III et al. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg 2009; 144: 14–18.
19. McCann J, Artinian V, Duhaime L et al. Evaluation of the causes for racial disparity in surgical treatment of early stage lung cancer. Chest 2005; 128: 3440–3446.
20. Gordon HS, Street RL Jr., Sharf BF et al. Racial differences in trust and lung cancer patients’ perceptions of physician communication. J Clin Oncol 2006; 24: 904–909.
21. Gordon HS, Street RL Jr., Sharf BF et al. Racial differences in doctors’ information-giving and patients’ participation. Cancer 2006; 107: 1313–1320.
22. Margolis ML, Christie JD, Silvestri GA et al. Racial differences pertaining to a belief about lung cancer surgery: Results of amulticenter survey. Ann Intern Med 2003; 139: 558–563.
23. Finkenauer R, Pomerleau CS, Snedecor SM et al. Race differences in factors relating to smoking initiation. Addict Behav 2009; 34: 1056–1059.
24. Trinidad DR, Gilpin EA, Lee L et al. Has there been a delay in the age of regular smoking onset among African Americans? Ann Behav Med 2004; 28: 152–157.
25. Haiman CA, Stram DO, Wilkens LR et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl JMed 2006; 354: 333–342.
26. de Dios MA, Anderson BJ, Stanton C et al. Project Impact: A pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers. J Subst Abuse Treat 2012; 43: 322–330.
27. Cokkinides VE, Halpern MT, Barbeau EM et al. Racial and ethnic disparities in smoking-cessation interventions: Analysis of the 2005 National Health Interview Survey. Am J Prev Med 2008; 34: 404–412.
28. Ryan KK, Garrett-Mayer E, Alberg AJ et al. Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers. Nicotine Tob Res 2011; 13: 646–652.
29. Croghan IT, Hurt RD, Ebbert JO et al. Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States. Z Gesundh Wiss 2010; 18: 59–68.
30. Fu SS, Sherman SE, Yano EM et al. Ethnic disparities in the use of nicotine replacement therapy for smoking cessation in an equal access health care system. Am J Health Promot 2005; 20: 108–116.
31. Carpenter MJ, Ford ME, Cartmell K et al. Misperceptions of nicotine replacement therapy within racially and ethnically diverse smokers. J Natl Med Assoc 2011; 103: 885–894.
32. Yerger VB, Wertz M, McGruder C et al. Nicotine replacement therapy: Perceptions of African-American smokers seeking to quit. J Natl Med Assoc 2008; 100: 230–236.
33. Lyna P, McBride C, Samsa G et al. Exploring the association between perceived risks of smoking and benefits to quitting: Who does not see the link? Addict Behav 2002; 27: 293–307.
34. Honda K, Neugut AI. Associations between perceived cancer riskandestablished risk factors ina national community sample. Cancer Detect Prev 2004; 28: 1–7.
35. Park ER, Ostroff JS, Rakowski W et al. Risk perceptions among participants undergoing lung cancer screening: Baseline results from the National Lung Screening Trial. Ann Behav Med 2009; 37: 268–279.
36. Lathan CS, Kumar P, Gareen IF et al. Racial differences in perceived risk in participants enrolled in the American College of Radiology (ACRIN-6654) arm of the National Lung Screening Trial (NLST). J Clin Oncol 2013; 31 (suppl): 1563a.
37. National Lung Screening Trial Research Team, Aberle DR, Berg CD et al. The National Lung Screening Trial: Overview and study design. Radiology 2011; 258: 243–253.
38. National Lung Screening Trial Research Team, Aberle DR, Adams AM et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010; 102: 1771–1779.
39. Heatherton TF, Kozlowski LT, Frecker RC et al. The Fagerström test for nicotine dependence: A revision of the Fagerström tolerance questionnaire. Br J Addict 1991; 86: 1119–1127.
40. Studts JL, Ghate SR, Gill JL et al. Validity of selfreported smoking status among participants in a lung cancer screening trial. Cancer Epidemiol Biomarkers Prev 2006; 15: 1825–1828.
41. Park ER, Gareen I, Duan F et al. Risk perceptions and smoking behaviors among participants of the ACRIN National Lung Screening Trial: One year follow-up. Society for Research on Nicotine and Tobacco Annual Meeting, Toronto, Ontario, 2011.
42. Centers for Disease Control and Prevention. Quitting smoking among adults—United States, 2001–2010. MMWR Morb Mortal Wkly Rep 2011; 60: 1513–1519.
43. Hymowitz N, Cummings KM, Hyland A et al. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control 1997; 6 (suppl 2): S57–S62.
44. King G, Polednak A, Bendel RB et al. Disparities in smoking cessation between African Americans and whites: 1990-2000. AmJ Public Health 2004; 94: 1965–1971.
45. Harris KJ, Okuyemi KS, Catley D et al. Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion. Prev Med 2004; 38: 498–502.
46. Okuyemi KS, Ebersole-Robinson M, Nazir N et al. African-American menthol and nonmenthol smokers: Differences in smoking and cessation experiences. J Natl Med Assoc 2004; 96: 1208–1211.
47. Gundersen DA, Delnevo CD, Wackowski O. Exploring the relationship between race/ethnicity, menthol smoking, and cessation, in a nationally representative sample of adults. Prev Med 2009; 49: 553–557.
48. Shmuely Y, Baumgarten M, Rovner B et al. Predictors of improvement in health-related quality of life among elderly patients with depression. Int Psychogeriatr 2001; 13: 63–73.
49. Tammemägi MC, Berg CD, Riley TL et al. Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst 2014; 106: dju084.
50. Slatore CG, Baumann C, Pappas M et al. Smoking behaviors among patients receiving computed tomography for lung cancer screening. Systematic review in support of the U. S. preventive services task force. Ann Am Thorac Soc 2014; 11: 619–627.
51. Zwar NA, Mendelsohn CP, Richmond RL. Tobacco smoking: Options for helping smokers to quit. Aust Fam Physician 2014; 43: 348–354.
52. Kendzor DE, Businelle MS, Cofta-Woerpel LM et al. Mechanisms linking socioeconomic disadvantage and BMI in smokers. Am J Health Behav 2013; 37: 587–598.
53. Kendzor DE, Businelle MS, Mazas CA et al. Pathways between socioeconomic status and modifiable risk factorsamong African Americansmokers. J Behav Med 2009; 32: 545–557.
54. Kendzor DE, Cofta-Woerpel LM, Mazas CA et al. Socioeconomic status, negative affect, and modifiable cancer risk factors in African-American smokers. Cancer Epidemiol Biomarkers Prev 2008; 17: 2546–2554.